Prediction of the Number of Patients Infected with COVID-19 Based on Rolling Grey Verhulst Models.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
25 06 2020
Historique:
received: 16 05 2020
revised: 20 06 2020
accepted: 23 06 2020
entrez: 8 7 2020
pubmed: 8 7 2020
medline: 24 7 2020
Statut: epublish

Résumé

The outbreak of a novel coronavirus (SARS-CoV-2) has caused a large number of residents in China to be infected with a highly contagious pneumonia recently. Despite active control measures taken by the Chinese government, the number of infected patients is still increasing day by day. At present, the changing trend of the epidemic is attracting the attention of everyone. Based on data from 21 January to 20 February 2020, six rolling grey Verhulst models were built using 7-, 8- and 9-day data sequences to predict the daily growth trend of the number of patients confirmed with COVID-19 infection in China. The results show that these six models consistently predict the S-shaped change characteristics of the cumulative number of confirmed patients, and the daily growth decreased day by day after 4 February. The predicted results obtained by different models are very approximate, with very high prediction accuracy. In the training stage, the maximum and minimum mean absolute percentage errors (MAPEs) are 4.74% and 1.80%, respectively; in the testing stage, the maximum and minimum MAPEs are 4.72% and 1.65%, respectively. This indicates that the predicted results show high robustness. If the number of clinically diagnosed cases in Wuhan City, Hubei Province, China, where COVID-19 was first detected, is not counted from 12 February, the cumulative number of confirmed COVID-19 cases in China will reach a maximum of 60,364-61,327 during 17-22 March; otherwise, the cumulative number of confirmed cases in China will be 78,817-79,780.

Identifiants

pubmed: 32630565
pii: ijerph17124582
doi: 10.3390/ijerph17124582
pmc: PMC7344860
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet Infect Dis. 2020 Jun;20(6):678-688
pubmed: 32213332
Infect Dis Model. 2020 Feb 14;5:256-263
pubmed: 32110742
Front Med (Lausanne). 2020 May 06;7:169
pubmed: 32435645
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
Lancet Infect Dis. 2020 Apr 27;:
pubmed: 32353347
J Clin Med. 2020 Mar 02;9(3):
pubmed: 32131537
Int J Environ Res Public Health. 2017 Nov 15;14(11):
pubmed: 29140266
BMJ. 2020 Apr 7;369:m1328
pubmed: 32265220
Int J Environ Res Public Health. 2017 Mar 04;14(3):
pubmed: 28273856
Sci Total Environ. 2020 Aug 1;728:138762
pubmed: 32334157
Int J Environ Res Public Health. 2015 Jun 25;12(7):7172-84
pubmed: 26121188
Sci China Life Sci. 2020 Mar;63(3):457-460
pubmed: 32009228
J Med Virol. 2020 Apr;92(4):408-417
pubmed: 31944312
Int J Environ Res Public Health. 2018 Oct 16;15(10):
pubmed: 30332771
Int J Environ Res Public Health. 2018 Mar 08;15(3):
pubmed: 29517985

Auteurs

Yu-Feng Zhao (YF)

School of Economics, Zhejiang University of Finance & Economics, Hangzhou 310018, China.

Ming-Huan Shou (MH)

School of Economics, Zhejiang University of Finance & Economics, Hangzhou 310018, China.

Zheng-Xin Wang (ZX)

School of Economics, Zhejiang University of Finance & Economics, Hangzhou 310018, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH